Evidence map›Paper›PMID 27891512›Full record

ArticleBioMed research international2016

A De-

Ji In Ryu, Shin Ae Park, Seo Ri Wui, Ara Ko, Ji Eun Han, Jung Ah Choi, Man Ki Song, Kwang Sung Kim, Yang Je Cho, Na Gyong Lee

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. UnderstandingCells · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ji In RyuDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Shin Ae ParkDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Seo Ri WuiDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Ara KoDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Ji Eun HanDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Jung Ah ChoiLaboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea.
Man Ki SongLaboratory Science Division, International Vaccine Institute, Seoul, Republic of Korea.ORCID 0000-0002-8279-9041
Kwang Sung KimR&D Center, EyeGene, Seoul, Republic of Korea.
Yang Je ChoR&D Center, EyeGene, Seoul, Republic of Korea.
Na Gyong LeeDepartment of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.ORCID 0000-0001-6842-9995
Sejong University · KRInternational Vaccine Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine adjuvants are agents that are used to promote immune responses to vaccine antigens and thereby to enhance the protective efficacy of the vaccines. In this study, we investigated the adjuvant activity of CIA06, an adjuvant system that is composed of a toll-like receptor 4 agonist de-

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, ViralFemaleInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesLipopolysaccharidesLungMiceMice, Inbred BALB COrthomyxoviridae InfectionsPneumoniaTh1 CellsAdjuvants, ImmunologicAntibodies, ViralInfluenza Vaccineslipid-linked oligosaccharidesLipopolysaccharides

Identifiers

PMID27891512
PMCPMC5116492
OpenAlexW2553247314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.